Poređenje robotske i laparoskopske hirurgije raka rektuma: meta-analiza randomiziranih kontroliranih studija.
World journal of surgical oncology
Sažetak istraživanja
Cilj Robotska i laparoskopska hirurgija raka rektuma se decenijama primenjuje u klinici; ipak, koji hirurški pristup ima nižu stopu postoperativnih komplikacija još uvijek nije jasno. Stoga je cilj ove meta-analize bio usporediti postoperativne komplikacije unutar 30 dana između robotske i laparoskopske operacije raka rektuma na temelju randomiziranih kontroliranih studija.
Metode Randomizirana kontrolirana ispitivanja (do maja 2020.) koja su upoređivala robotsku i laparoskopsku hirurgiju raka rektuma pretražena su putem PubMed-a, EMBASE-a, Cochrane biblioteke, Kineske nacionalne infrastrukture znanja (CNKI), Wanfang Data Knowledge Service Platform i China Biology Medicine diska (CBMdis). Podaci o veličini uzorka, kliničkim i demografskim karakteristikama i postoperativnim komplikacijama u roku od 30 dana, uključujući ukupne postoperativne komplikacije, teške postoperativne komplikacije (Clavien-Dindo skor ≥ III), curenje anastomoze, infekciju kirurškog mjesta, krvarenje, ileus, komplikacije urina, respiratorne komplikacije i reoperativnu operaciju, neoperativnu operaciju ekstrahovani su patološki ishodi.
Rezultati su analizirani pomoću RevMan v5.3.
Rezultati Uključeno je sedam randomiziranih kontroliranih studija koje su uključivale 507 robotskih i 516 laparoskopskih slučajeva raka rektuma. Meta-analiza je pokazala da su ukupne postoperativne komplikacije u roku od 30 dana [Z = 1.1, OR = 1.18, 95% CI (0.88-1.57), P = 0.27], teške postoperativne komplikacije [Z = 0.22, OR = 1.12, 95% CI = 0.7, 18% CI = 0.7 curenje iz anastomoze [Z = 0,96, OR = 1,27, 95% CI (0,78-2,08), P = 0,34], infekcija hirurškog mesta [Z = 0,18, OR = 1,05, 95% CI (0,61-1,79), P = 0, 0, 0. Z = 0,9. 0,89, 95% CI (0,27-2,97), P = 0,85], ileus [Z = 1,47, OR = 0,66, 95% CI (0,38-1,15), P = 0,14], komplikacije urinarnog sistema [Z = 0,66, 2 OR, 5% (0,67-2,22), P = 0,51], respiratorne komplikacije [Z = 0,84, OR = 0,64, 95% CI (0,22-1,82), P = 0,40], konverzija na otvorenu operaciju [Z = 1,73, OR = 0,61, 95% CI = 0,75% CI = 0,75% CI neplanirana reoperacija [Z = 0,14, OR = 0,91, 95% CI (0,26-3,20), P = 0,89], perioperativni mortalitet [Z = 0,28, OR = 0,79, 95% CI (0,15-4,12), P = 0,15% CI (0,15-4,12), P = 8 i 0,0. laparoskopska rektalna hirurgija.
Zaključak Robotska hirurgija raka rektuma bila je uporediva sa laparoskopskom hirurgijom u pogledu postoperativnih komplikacija unutar 30 dana.
Prikaži originalni naslov i sažetak na engleskom
Comparison of robotic and laparoscopic rectal cancer surgery: a meta-analysis of randomized controlled trials.
Objective Robotic and laparoscopic surgery for rectal cancer has been applied in the clinic for decades; nevertheless, which surgical approach has a lower rate of postoperative complications is still inconclusive. Therefore, the aim of this meta-analysis was to compare the postoperative complications within 30 days between robotic and laparoscopic rectal cancer surgery based on randomized controlled trials.
Methods Randomized controlled trials (until May 2020) that compared robotic and laparoscopic rectal cancer surgery were searched through PubMed, EMBASE, the Cochrane Library, China National Knowledge Infrastructure (CNKI), Wanfang Data Knowledge Service Platform, and China Biology Medicine disc (CBMdisc). Data regarding sample size, clinical and demographic characteristics, and postoperative complications within 30 days, including overall postoperative complications, severe postoperative complications (Clavien-Dindo score ≥ III), anastomotic leakage, surgical site infection, bleeding, ileus, urinary complications, respiratory complications, conversion to open surgery, unscheduled reoperation, perioperative mortality, and pathological outcomes, were extracted. The results were analyzed using RevMan v5.3.
Results Seven randomized controlled trials that included 507 robotic and 516 laparoscopic rectal cancer surgery cases were included. Meta-analysis showed that the overall postoperative complications within 30 days [Z = 1.1, OR = 1.18, 95% CI (0.88-1.57), P = 0.27], severe postoperative complications [Z = 0.22, OR = 1.12, 95% CI (0.41-3.07), P = 0.83], anastomotic leakage [Z = 0.96, OR = 1.27, 95% CI (0.78-2.08), P = 0.34], surgical site infection [Z = 0.18, OR = 1.05, 95% CI (0.61-1.79), P = 0.86], bleeding [Z = 0.19, OR = 0.89, 95% CI (0.27-2.97), P = 0.85], ileus [Z = 1.47, OR = 0.66, 95% CI (0.38-1.15), P = 0.14], urinary complications [Z = 0.66, OR = 1.22, 95% CI (0.67-2.22), P = 0.51], respiratory complications [Z = 0.84, OR = 0.64, 95% CI (0.22-1.82), P = 0.40], conversion to open surgery [Z = 1.73, OR = 0.61, 95% CI (0.35-1.07), P = 0.08], unscheduled reoperation [Z = 0.14, OR = 0.91, 95% CI (0.26-3.20), P = 0.89], perioperative mortality [Z = 0.28, OR = 0.79, 95% CI (0.15-4.12), P = 0.78], and pathological outcomes were similar between robotic and laparoscopic rectal surgery.
Conclusion Robotic surgery for rectal cancer was comparable to laparoscopic surgery with respect to postoperative complications within 30 days.
Izvorni podaci
- DOI
- 10.1186/s12957-021-02128-2
- PMID
- 33536032
- PMCID
- PMC7860622
- Provjereno
- 2026-07-26
Naslov i sažetak prevedeni su automatski i prijevod može sadržavati netačnosti ili neprecizne stručne izraze. Za sve detalje, citiranje i medicinsko tumačenje pregledajte originalnu englesku verziju članka. Ne donosite zdravstvene odluke samo na osnovu ovog prijevoda.
Pregledaj originalni članak na engleskom